Products

Products

World-class data science drives analytics and applications all accessible from the IntegriChain ICyte Platform combined with outstanding leading Managed Service offerings

Webinar

The Current State of Drug Pricing Transparency

As more states adopt drug pricing transparency laws to help lower the cost of prescription drugs, pharmaceutical manufacturers, especially those about to launch their first therapy, must understand the changing legal landscape and what it means for their business now and in the future.
Watch THE WEBINAR

 eBook

Improving Revenue Leakage Through Better Medicaid Claims Validation

With a growing population of program participants, the amount of Claim Level Data (CLD) will continue to grow exponentially. Invoice level validations alone cannot bring to light all the potential disputes in the Medicaid data. Without a solid CLD strategy in place, manufacturers are prone to errors and significant revenue leakage.
READ eBOOK

Webinar

Case Study: Real World GTN Transformation using Data and Analytics

Listen OnDemand to Jen Sharpe, Executive Director, Gross-to-Net Solutions of IntegriChain, Kary Callahan, Director, Commercial Finance of Paratek, and Tina Knell, Assistant Director, Revenue of BridgeBio discuss real world GTN transformation using data and analytics. This session was presented at InformaConnect’s BioPharma CFO Digital Week.
WATCH THE WEBINAR

 Case Study

Gross-to-Net 2021: Benchmark Survey Report

In the past year, COVID-19 has expedited efforts for pharmaceutical manufacturers to adopt improved and automated solutions to accurately manage their Gross-to-Net (GTN) forecasting and accrual processes.

READ THE CASE STUDY

specialty analytics

 Infographic

Drug Commercialization 101

If you’re having trouble assembling your vision for market access success, you don’t have to do it alone. IntegriChain has helped launch more than 120 brands in the past 3 years, including more than 40 first time launches.
READ THE INFOGRAPHIC

Article

Market Access Benchmark Advisory

Download our data sheet to see how IntegriChain’s Market Access Benchmark Advisory Service can help manufacturers revamp their channel, payer and specialty pharmacy strategy using data-driven insights.

DOWNLOAD THE ARTICLE

distribution analytics

distribution analytics

 Case Study

Lessons Learned from a Non-linear Product Launch

A life sciences manufacturer recently launched their first product and faced many challenges along the way. They knew that in order to maximize market access success, they needed a technology partner who was flexible enough to help them scale and adjust for their specific needs and circumstances.
READ THE CASE STUDY

 Webinar

INSIGHTS SERIES – Trends in Vaccine and Anti-Viral Drug Distribution and Channel Insights

COVID-19 has thrust vaccines and new drug innovations to combat viruses front-and-center in the news. During this webinar, IntegriChain will review data and insights to project what the future of COVID therapies may look like.

WATCH THE WEBINAR

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand